Collaboration to Accelerate NGS and Immunology Diagnostic To

Collaboration to Accelerate NGS and Immunology Diagnostic Tools Announced


Apr 14 2021 Read 11 Times
Mayo Clinic, a nonprofit organisation committed to innovation in clinical practice, education and research, and Thermo Fisher Scientific have joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialisation of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The Advanced Diagnostics Laboratory in One Discovery Square, which is part of the Destination Medical Center initiative, will be the home for this collaboration.
 
"By pairing cutting-edge, innovative technologies with world-class clinical and diagnostic testing knowledge, this collaboration will ensure that the promising innovations are both clinically relevant and accessible globally," said William Morice II, MD, PhD, chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology and president of Mayo Clinic Laboratories. 

Related Keywords

Gianluca Pettiti , Mayo Clinic Department Of Laboratory Medicine , Diagnostics Laboratory In One Discovery Square , Thermo Fisher , Destination Medical Center , Mayo Clinic , Thermo Fisher Scientific , Advanced Diagnostics Laboratory , One Discovery Square , William Morice , Laboratory Medicine , Senior Vice President , Specialty Diagnostics , மயோ சிகிச்சையகம் துறை ஆஃப் ஆய்வகம் மருந்து , தெர்மோ மீனவர் , இலக்கு மருத்துவ மையம் , மயோ சிகிச்சையகம் , தெர்மோ மீனவர் அறிவியல் , ஒன்று கண்டுபிடிப்பு சதுரம் , வில்லியம் மோரிஸ் , ஆய்வகம் மருந்து , மூத்தவர் துணை ப்ரெஸிடெஂட் , சிறப்பு பரிசோதனை ,

© 2025 Vimarsana